CZChaogeng Zhu

Chaogeng Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chaogeng Zhu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Xu

    Central Laboratory, Hunan Provincial People’s Hospital (the First Affiliated Hospital of Hunan Normal University), Changsha, China

    2 shared publications
  • Xiangli Ye

    Affiliation Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, China

    2 shared publications
  • Yongzhong Shi

    Institute of Translational Medicine, Hunan Provincial People's Hospital The First Affiliated Hospital of Hunan Normal University Changsha China

    2 shared publications
  • Daixin Wang

    A Institute of Clinical Medicine, Translational Medicine Laboratory of Pancreatic Diseases, the First Affiliated Hospital of Hunan Normal University; Hunan Provincial People's Hospital , Changsha , Hunan , China 410005

    1 shared publication
  • Dandan Zhang

    Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics

    1 shared publication
  • Guiyun He

    Department of Ophthalmology, Hunan Provincial People's Hospital The First Affiliated Hospital of Hunan Normal University Changsha China

    1 shared publication

Latest Publications

  • Open Access

    Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge

    by Chaogeng Zhu, Guiyun He, Qinqin Yin, Lin Zeng, Xiangli Ye, Yongzhong Shi, Wei Xu

    The global coronavirus disease 2019 (COVID‐19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has led to an unprecedented worldwide public health emergency. Despite the concerted efforts of the scientific field, by April 25, 2021, SARS‐CoV‐2 had spread to over 192 countries/regions, causing more than 146 million confirmed cases including 31 million deaths. For now, an established treatment for patients with COVID‐19 remains unavailable. The key to tackling this pandemic is to understand the mechanisms underlying its infectivity and pathogenicity. As a predominant focus, the coronavirus spike (S) protein is the key determinant of host range, infectivity, and pathogenesis. Thereby comprehensive understanding of the sophisticated structure of SARS‐CoV‐2 S protein may provide insights into possible intervention strategies to fight this ongoing global pandemic. Herein, we summarize the current knowledge of the molecular structural and functional features of SARS‐CoV‐2 S protein as well as recent updates on the cell entry mechanism of the SARS‐CoV‐2, paving the way for exploring more structure‐guided strategies against SARS‐CoV‐2.


  • Mutation analysis of 21 autosomal short tandem repeats in Han population from Hunan, China

    by Wei Xu, Yuequn Wang, Dandan Zhang, Daixin Wang, Liang Zhou, Xiangli Ye, Chaogeng Zhu, Yongzhong Shi

    Background: Short tandem repeats (STRs), are powerful genetic markers widely used in human genetics. Population data and locus-specific mutation rates of STRs are crucial for the evaluation and interpretation of genetic evidence in forensic and population genetics. Aim: To investigate the mutation rates of 21 autosomal STRs in a population from central south China. Subjects and methods: We analysed 3,420 paternity cases with a Combined Paternity Index≧10,000 from Han population in Hunan. A total of 68,743 meiotic transfers were analysed and 62 mutations were identified. Results: The overall mutation rate of STR loci was 0.9 x10−3 (95%CI, 0.0007-0.0011) , and the locus-specific mutation rates were estimated ranging from 0.0000 to 0.0023. Locus D1S1656 exhibited the highest mutation rate of 2.3 x10−3 (95%CI, 0.0005-0.0006) , followed by D12S391 with a mutation rate of 2.0 x10−3 (95%CI, 0.0007-0.0044) . No mutation was observed at TPOX, D2S1338 or Penta D. One-step mutation cases accounted for 96.77% of total mutations and the ratio of paternal versus maternal mutations was about 4.85:1. Conclusion: Inter-population comparisons of locus-specific mutation rates of several STRs revealed significant difference between Han in Hunan and Han in other regions in China. Our data support the use of geographical data in further genetic applications.